{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:56:51Z","timestamp":1790632611919,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00284-026-05105-8","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:59:49Z","timestamp":1787741989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial Peptides as Eco-Innovative Therapeutics to Overcome Antifungal Pressure-Induced Resistance in Candida Infections"],"prefix":"10.1007","volume":"83","author":[{"given":"Bahgat","family":"Fayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"5105_CR1","unstructured":"World Health O (2022) WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization"},{"issue":"1","key":"5105_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18502\/cmm.7.1.6181","volume":"7","author":"NEY A ME-G","year":"2021","unstructured":"A ME-G NEY, H AK (2021) Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt. Curr Med Mycol 7(1):31\u201337. https:\/\/doi.org\/10.18502\/cmm.7.1.6181","journal-title":"Curr Med Mycol"},{"issue":"4","key":"5105_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jac\/dkx480","volume":"73","author":"A Chowdhary","year":"2018","unstructured":"Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF (2018) A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 73(4):891\u2013899. https:\/\/doi.org\/10.1093\/jac\/dkx480","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5105_CR4","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1186\/s12879-024-10007-w","volume":"24","author":"HSA Aziz","year":"2024","unstructured":"Aziz HSA, Ismail DK, Mohammed NSA, Elgendy MO, Bassiouny DM (2024) Distribution and antifungal susceptibility profiles of Candida species isolated from candidemia patients admitted to Egyptian tertiary hospitals: a cross-sectional study. BMC Infect Dis 24(1):1177. https:\/\/doi.org\/10.1186\/s12879-024-10007-w","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5105_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00284-023-03416-8","volume":"80","author":"B Fayed","year":"2023","unstructured":"Fayed B, Lazreg IK, AlHumaidi RB, Qasem MA, Alajmy BMGN, Bojbarah FM, Senok A, Husseiny MI, Soliman SS (2023) Intra-clade Heterogeneity in Candida auris: Risk of Management. Curr Microbiol 80(9):295","journal-title":"Curr Microbiol"},{"key":"5105_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12866-025-04055-8","volume":"25","author":"B Fayed","year":"2025","unstructured":"Fayed B (2025) Insights into Candida auris dispersal cells and their impact on antifungal resistance. BMC Microbiol 25:342","journal-title":"BMC Microbiol"},{"issue":"2","key":"5105_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/jof11020087","volume":"11","author":"AH Abu-Humaidan","year":"2025","unstructured":"Abu-Humaidan AH, Alshdaifat A, Awajan D, Abu-Hmidan M, Alshdifat A, Hasan H, Ahmad FM, Alaridah N, Irshaid A, Yamin D (2025) The Antimicrobial Resistance of Candida: A 5-Year Retrospective Analysis at a Tertiary Hospital in Jordan. J Fungi 11(2):87","journal-title":"J Fungi"},{"key":"5105_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijid.2018.02.005","volume":"70","author":"A Alatoom","year":"2018","unstructured":"Alatoom A, Sartawi M, Lawlor K, AbdelWareth L, Thomsen J, Nusair A, Mirza I (2018) Persistent candidemia despite appropriate fungal therapy: First case of Candida auris from the United Arab Emirates. Int J Infect Dis 70:36\u201337. https:\/\/doi.org\/10.1016\/j.ijid.2018.02.005","journal-title":"Int J Infect Dis"},{"issue":"2","key":"5105_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1556\/030.2025.02615","volume":"72","author":"S Solak Grassie","year":"2025","unstructured":"Solak Grassie S, Karab\u0131\u00e7ak N, \u00dcnalan Alt\u0131ntop T (2025) Candida auris infections in an intensive care unit: Antifungal resistance, mortality rates and infection control interventions. Acta Microbiol Immunol Hung 72(2):164\u2013170. https:\/\/doi.org\/10.1556\/030.2025.02615","journal-title":"Acta Microbiol Immunol Hung"},{"key":"5105_CR10","doi-asserted-by":"publisher","unstructured":"Akinosoglou K, Skintzi K, Chandroulis I, Polyzou E, Siapika A, Fligkou F, Paliogianni F, Gogos C, Dimopoulos G (2025) Patterns and Predictors of Candida auris Candidemia with Multidrug-Resistant Bacterial Co-Infections: Results from the CANDI-MDR Study. J Fungi (Basel) 11(6). https:\/\/doi.org\/10.3390\/jof11060407","DOI":"10.3390\/jof11060407"},{"key":"5105_CR11","doi-asserted-by":"publisher","unstructured":"G\u00fclten E, \u00c7\u0131nar G, Sar\u0131cao\u011flu EM, Akdemir \u0130, Y\u0131lmaz AZ, Saldere EH, Y\u00f6r\u00fck F (2025) Candida auris vs. Non-Candida auris Candidemia in Critically Ill Patients: Clinical Outcomes, Risk Factors, and Mortality. J Fungi (Basel) 11(8). https:\/\/doi.org\/10.3390\/jof11080552","DOI":"10.3390\/jof11080552"},{"issue":"7","key":"5105_CR12","doi-asserted-by":"publisher","first-page":"e70085","DOI":"10.1111\/myc.70085","volume":"68","author":"CC de Melo","year":"2025","unstructured":"de Melo CC, de Oliveira HLNL, Souza BR, Moura CVR, Oliveira R, Bastos RW, Kemmerich KK, de Almeida-J\u00fanior JN, Colombo AL, Spruijtenburg B, Meis JF, Le Pape P, Moonen CGJ, de Lima-Neto RG (2025) Clade Distinction and Tracking of Clonal Spread by Fourier-Transform Infrared Spectroscopy in Multicenter Candida (Candidozyma) auris Outbreak. Mycoses 68(7):e70085. https:\/\/doi.org\/10.1111\/myc.70085","journal-title":"Mycoses"},{"key":"5105_CR13","doi-asserted-by":"publisher","unstructured":"Nguyen MD, Ren P (2025) Trends in Antifungal Resistance Among Candida Species: An Eight-Year Retrospective Study in the Galveston-Houston Gulf Coast Region. J Fungi (Basel) 11(3). https:\/\/doi.org\/10.3390\/jof11030232","DOI":"10.3390\/jof11030232"},{"key":"5105_CR14","doi-asserted-by":"publisher","first-page":"128322","DOI":"10.1016\/j.micres.2025.128322","volume":"301","author":"ZK Ross","year":"2025","unstructured":"Ross ZK, Alsayegh S, Zhao Y, McPherson S, Munro CA, Lorenz A (2025) In vitro evolution of caspofungin resistance in Candidozyma auris via FKS1 hotspot I mutations results in moderate fitness trade-offs but no reduction in virulence. Microbiol Res 301:128322. https:\/\/doi.org\/10.1016\/j.micres.2025.128322","journal-title":"Microbiol Res"},{"key":"5105_CR15","doi-asserted-by":"publisher","unstructured":"Fayed B, El-Sayed HS, Luo S, Reda AE (2025) Comparative evaluation of biologically and chemically synthesized zinc oxide nanoparticles for preventing Candida auris biofilm. https:\/\/doi.org\/10.1007\/s10534-025-00678-6. Biometals","DOI":"10.1007\/s10534-025-00678-6"},{"key":"5105_CR16","doi-asserted-by":"publisher","unstructured":"Rybak JM, Mu\u00f1oz JF, Barker KS, Parker JE, Esquivel BD, Berkow EL, Lockhart SR, Gade L, Palmer GE, White TC, Kelly SL, Cuomo CA, Rogers PD (2020) Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris. mBio 11(3). https:\/\/doi.org\/10.1128\/mBio.00365-20","DOI":"10.1128\/mBio.00365-20"},{"issue":"6","key":"5105_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/17460913.2025.2480924","volume":"20","author":"J De Paiva Macedo","year":"2025","unstructured":"De Paiva Macedo J, Watanabe AAS, Machado ABF, Diniz CG, Da Silva VL, Dias VC (2025) Unveiling antifungal resistance and biocide tolerance in clinical isolates of Candida spp. Future Microbiol 20(6):457\u2013468. https:\/\/doi.org\/10.1080\/17460913.2025.2480924","journal-title":"Future Microbiol"},{"key":"5105_CR18","doi-asserted-by":"publisher","unstructured":"Czajka KM, Venkataraman K, Brabant-Kirwan D, Santi SA, Verschoor C, Appanna VD, Singh R, Saunders DP, Tharmalingam S (2023) Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species. Cells 12(22). https:\/\/doi.org\/10.3390\/cells12222655","DOI":"10.3390\/cells12222655"},{"issue":"6","key":"5105_CR19","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmi.2021.11.024","volume":"28","author":"JM Rybak","year":"2022","unstructured":"Rybak JM, Barker KS, Mu\u00f1oz JF, Parker JE, Ahmad S, Mokaddas E, Abdullah A, Elhagracy RS, Kelly SL, Cuomo CA, Rogers PD (2022) In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin Microbiol Infect 28(6):838\u2013843. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.024","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5105_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12934-025-02767-0","volume":"24","author":"SA Ismail","year":"2025","unstructured":"Ismail SA, Shalaby HM, Hassan AA, Mahmoud M, Fayed B (2025) Protease production by Serratia liquefaciens NRC1 using fish gut waste as a sustainable approach to antimicrobial peptide generation and combating Candida auris acquired resistance. Microb Cell Fact 24(1):155","journal-title":"Microb Cell Fact"},{"issue":"11","key":"5105_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/fermentation10110540","volume":"10","author":"X Ma","year":"2024","unstructured":"Ma X, Wang Q, Ren K, Xu T, Zhang Z, Xu M, Rao Z, Zhang X (2024) A Review of Antimicrobial Peptides: Structure, Mechanism of Action, and Molecular Optimization Strategies. Fermentation 10(11):540","journal-title":"Fermentation"},{"key":"5105_CR22","doi-asserted-by":"publisher","first-page":"649875","DOI":"10.3389\/fcell.2021.649875","volume":"9","author":"C Struyfs","year":"2021","unstructured":"Struyfs C, Cammue BPA, Thevissen K (2021) Membrane-Interacting Antifungal Peptides. Front cell Dev biology 9:649875. https:\/\/doi.org\/10.3389\/fcell.2021.649875","journal-title":"Front cell Dev biology"},{"key":"5105_CR23","doi-asserted-by":"publisher","unstructured":"Wang H, Zhang C, Li M, Liu C, Wang J, Ou X, Han Y (2022) Antimicrobial Peptides Mediate Apoptosis by Changing Mitochondrial Membrane Permeability. Int J Mol Sci 23(21). https:\/\/doi.org\/10.3390\/ijms232112732","DOI":"10.3390\/ijms232112732"},{"issue":"12","key":"5105_CR24","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/mmy\/myab059","volume":"59","author":"B Fayed","year":"2021","unstructured":"Fayed B, Jayakumar MN, Soliman SS (2021) Caspofungin-resistance in Candida auris is cell wall-dependent phenotype and potential prevention by zinc oxide nanoparticles. Med Mycol J 59(12):1243\u20131256","journal-title":"Med Mycol J"},{"key":"5105_CR25","doi-asserted-by":"publisher","unstructured":"Popp C, Ram\u00edrez-Zavala B, Schwanfelder S, Kr\u00fcger I, Morschh\u00e4user J (2019) Evolution of Fluconazole-Resistant Candida albicans Strains by Drug-Induced Mating Competence and Parasexual Recombination. mBio 10(1). https:\/\/doi.org\/10.1128\/mBio.02740-18","DOI":"10.1128\/mBio.02740-18"},{"issue":"3","key":"5105_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2958.2012.08210.x","volume":"86","author":"C Sasse","year":"2012","unstructured":"Sasse C, Dunkel N, Sch\u00e4fer T, Schneider S, Dierolf F, Ohlsen K, Morschh\u00e4user J (2012) The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans. Mol Microbiol 86(3):539\u2013556. https:\/\/doi.org\/10.1111\/j.1365-2958.2012.08210.x","journal-title":"Mol Microbiol"},{"key":"5105_CR27","volume-title":"Clinical and laboratory standards institute (clsi): Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","author":"PJCS Wayne","year":"2008","unstructured":"Wayne PJCS (2008) Clinical and laboratory standards institute (clsi): Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Allured Publishing Corporation, IL"},{"issue":"7","key":"5105_CR28","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1128\/aac.48.7.2477-2482.2004","volume":"48","author":"E Cant\u00f3n","year":"2004","unstructured":"Cant\u00f3n E, Pem\u00e1n J, Gobernado M, Viudes A, Espinel-Ingroff A (2004) Patterns of amphotericin B killing kinetics against seven Candida species. Antimicrob Agents Chemother 48(7):2477\u20132482. https:\/\/doi.org\/10.1128\/aac.48.7.2477-2482.2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5105_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP (2017) Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis 64(2):134\u2013140. https:\/\/doi.org\/10.1093\/cid\/ciw691","journal-title":"Clin Infect Dis"},{"key":"5105_CR30","doi-asserted-by":"publisher","unstructured":"Keighley C, Gall M, van Hal SJ, Halliday CL, Chai LYA, Chew KL, Biswas C, Slavin MA, Meyer W, Sintchenko V, Chen SCA (2022) Whole Genome Sequencing Shows Genetic Diversity, as Well as Clonal Complex and Gene Polymorphisms Associated with Fluconazole Non-Susceptible Isolates of Candida tropicalis. J fungi (Basel Switzerland) 8(9). https:\/\/doi.org\/10.3390\/jof8090896","DOI":"10.3390\/jof8090896"},{"issue":"7","key":"5105_CR31","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1128\/aac.01127-10","volume":"55","author":"AP Silva","year":"2011","unstructured":"Silva AP, Miranda IM, Guida A, Synnott J, Rocha R, Silva R, Amorim A, Pina-Vaz C, Butler G, Rodrigues AG (2011) Transcriptional profiling of azole-resistant Candida parapsilosis strains. Antimicrob Agents Chemother 55(7):3546\u20133556. https:\/\/doi.org\/10.1128\/aac.01127-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5105_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1128\/aac.41.3.535","volume":"41","author":"HM Calvet","year":"1997","unstructured":"Calvet HM, Yeaman MR, Filler SG (1997) Reversible fluconazole resistance in Candida albicans: a potential in vitro model. Antimicrob Agents Chemother 41(3):535\u2013539. https:\/\/doi.org\/10.1128\/aac.41.3.535","journal-title":"Antimicrob Agents Chemother"},{"key":"5105_CR33","doi-asserted-by":"publisher","first-page":"e00662","DOI":"10.7554\/eLife.00662","volume":"4","author":"CB Ford","year":"2015","unstructured":"Ford CB, Funt JM, Abbey D, Issi L, Guiducci C, Martinez DA, Delorey T, Li BY, White TC, Cuomo C (2015) The evolution of drug resistance in clinical isolates of Candida albicans. eLife 4:e00662","journal-title":"eLife"},{"issue":"11","key":"5105_CR34","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1128\/ec.05168-11","volume":"10","author":"M Huang","year":"2011","unstructured":"Huang M, McClellan M, Berman J, Kao KC (2011) Evolutionary dynamics of Candida albicans during in vitro evolution. Eukaryot Cell 10(11):1413\u20131421. https:\/\/doi.org\/10.1128\/ec.05168-11","journal-title":"Eukaryot Cell"},{"key":"5105_CR35","doi-asserted-by":"publisher","unstructured":"Todd RT, Soisangwan N, Peters S, Kemp B, Crooks T, Gerstein A, Selmecki A (2023) Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans. Mol Biol Evol 40(1). https:\/\/doi.org\/10.1093\/molbev\/msad009","DOI":"10.1093\/molbev\/msad009"},{"issue":"10","key":"5105_CR36","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1128\/aac.00620-16","volume":"60","author":"JB Locke","year":"2016","unstructured":"Locke JB, Almaguer AL, Zuill DE, Bartizal K (2016) Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species. Antimicrob Agents Chemother 60(10):6100\u20136107. https:\/\/doi.org\/10.1128\/aac.00620-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"5105_CR37","doi-asserted-by":"publisher","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","volume":"11","author":"BM Vincent","year":"2013","unstructured":"Vincent BM, Lancaster AK, Scherz-Shouval R, Whitesell L, Lindquist S (2013) Fitness trade-offs restrict the evolution of resistance to amphotericin B. PLoS Biol 11(10):e1001692","journal-title":"PLoS Biol"},{"issue":"6","key":"5105_CR38","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1128\/aac.44.6.1578-1584.2000","volume":"44","author":"F Barchiesi","year":"2000","unstructured":"Barchiesi F, Calabrese D, Sanglard D, Di Falconi L, Caselli F, Giannini D, Giacometti A, Gavaudan S, Scalise G (2000) Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44(6):1578\u20131584. https:\/\/doi.org\/10.1128\/aac.44.6.1578-1584.2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5105_CR39","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1567-1364.2009.00508.x","volume":"9","author":"AT Pinto e Silva","year":"2009","unstructured":"Pinto e Silva AT, Costa-de-Oliveira S, Silva-Dias A, Pina-Vaz C, Rodrigues AG (2009) Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles. FEMS Yeast Res 9(4):626\u2013633","journal-title":"FEMS Yeast Res"},{"issue":"12","key":"5105_CR40","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1038\/s41564-024-01854-z","volume":"9","author":"H Carolus","year":"2024","unstructured":"Carolus H, Sofras D, Boccarella G, Sephton-Clark P, Biriukov V, Cauldron NC, Lobo Romero C, Vergauwen R, Yazdani S, Pierson S, Jacobs S, Vandecruys P, Wijnants S, Meis JF, Gabald\u00f3n T, van den Berg P, Rybak JM, Cuomo CA, Van Dijck P (2024) Acquired amphotericin B resistance leads to fitness trade-offs that can be mitigated by compensatory evolution in Candida auris. Nat Microbiol 9(12):3304\u20133320. https:\/\/doi.org\/10.1038\/s41564-024-01854-z","journal-title":"Nat Microbiol"},{"issue":"4","key":"5105_CR41","doi-asserted-by":"publisher","first-page":"e0097724","DOI":"10.1128\/msphere.00977-24","volume":"10","author":"T Phan-Canh","year":"2025","unstructured":"Phan-Canh T, Nguyen-Le DM, Luu PL, Khunweeraphong N, Kuchler K (2025) Rapid in vitro evolution of flucytosine resistance in Candida auris. mSphere 10(4):e0097724. https:\/\/doi.org\/10.1128\/msphere.00977-24","journal-title":"mSphere"},{"issue":"1","key":"5105_CR42","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1080\/21505594.2021.1927609","volume":"12","author":"V Lara-Aguilar","year":"2021","unstructured":"Lara-Aguilar V, Rueda C, Garc\u00eda-Barbaz\u00e1n I, Varona S, Monz\u00f3n S, Jim\u00e9nez P, Cuesta I, Zaballos \u00c1, Zaragoza \u00d3 (2021) Adaptation of the emerging pathogenic yeast Candida auris to high caspofungin concentrations correlates with cell wall changes. Virulence 12(1):1400\u20131417. https:\/\/doi.org\/10.1080\/21505594.2021.1927609","journal-title":"Virulence"},{"key":"5105_CR43","doi-asserted-by":"publisher","unstructured":"Bing J, Hu T, Zheng Q, Mu\u00f1oz JF, Cuomo CA, Huang G (2020) Experimental Evolution Identifies Adaptive Aneuploidy as a Mechanism of Fluconazole Resistance in Candida auris. Antimicrob Agents Chemother 65(1). https:\/\/doi.org\/10.1128\/aac.01466-20","DOI":"10.1128\/aac.01466-20"},{"key":"5105_CR44","doi-asserted-by":"publisher","unstructured":"Weil T, Santamar\u00eda R, Lee W, Rung J, Tocci N, Abbey D, Bezerra AR, Carreto L, Moura GR, Bay\u00e9s M, Gut IG, Csikasz-Nagy A, Cavalieri D, Berman J, Santos MAS (2017) Adaptive Mistranslation Accelerates the Evolution of Fluconazole Resistance and Induces Major Genomic and Gene Expression Alterations in Candida albicans. 2(4). https:\/\/doi.org\/10.1128\/msphere.00167-17. msphere.00167\u2009\u2013\u200900117","DOI":"10.1128\/msphere.00167-17"},{"issue":"2","key":"5105_CR45","doi-asserted-by":"publisher","first-page":"e0022723","DOI":"10.1128\/mbio.00227-23","volume":"14","author":"F Yang","year":"2023","unstructured":"Yang F, Scopel EFC, Li H, Sun LL, Kawar N, Cao YB, Jiang YY, Berman J (2023) Antifungal Tolerance and Resistance Emerge at Distinct Drug Concentrations and Rely upon Different Aneuploid Chromosomes. mBio 14(2):e0022723. https:\/\/doi.org\/10.1128\/mbio.00227-23","journal-title":"mBio"},{"issue":"10","key":"5105_CR46","doi-asserted-by":"publisher","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","volume":"11","author":"BM Vincent","year":"2013","unstructured":"Vincent BM, Lancaster AK, Scherz-Shouval R, Whitesell L, Lindquist S (2013) Fitness trade-offs restrict the evolution of resistance to amphotericin B. PLoS Biol 11(10):e1001692. https:\/\/doi.org\/10.1371\/journal.pbio.1001692","journal-title":"PLoS Biol"},{"issue":"12","key":"5105_CR47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/myc.13655","volume":"66","author":"B Spruijtenburg","year":"2023","unstructured":"Spruijtenburg B, Ahmad S, Asadzadeh M, Alfouzan W, Al-Obaid I, Mokaddas E, Meijer EFJ, Meis JF, de Groot T (2023) Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates. Mycoses 66(12):1079\u20131086. https:\/\/doi.org\/10.1111\/myc.13655","journal-title":"Mycoses"},{"key":"5105_CR48","doi-asserted-by":"publisher","unstructured":"Al-Obaid I, Asadzadeh M, Ahmad S, Alobaid K, Alfouzan W, Bafna R, Emara M, Joseph L (2022) Fatal Breakthrough Candidemia in an Immunocompromised Patient in Kuwait Due to Candida auris Exhibiting Reduced Susceptibility to Echinocandins and Carrying a Novel Mutation in Hotspot-1 of FKS1. Journal of fungi (Basel. Switzerland) 8(3). https:\/\/doi.org\/10.3390\/jof8030267","DOI":"10.3390\/jof8030267"},{"issue":"8","key":"5105_CR49","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1128\/jcm.00381-07","volume":"45","author":"JH Shin","year":"2007","unstructured":"Shin JH, Chae MJ, Song JW, Jung SI, Cho D, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW (2007) Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia. J Clin Microbiol 45(8):2385\u20132391. https:\/\/doi.org\/10.1128\/jcm.00381-07","journal-title":"J Clin Microbiol"},{"issue":"10","key":"5105_CR50","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1128\/aac.00473-08","volume":"52","author":"GR Thompson","year":"2008","unstructured":"Thompson GR 3rd, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS 2nd, Patterson TF (2008) Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Chemother 52(10):3783\u20133785. https:\/\/doi.org\/10.1128\/aac.00473-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"5105_CR51","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1128\/jcm.03593-13","volume":"52","author":"T Saraya","year":"2014","unstructured":"Saraya T, Tanabe K, Araki K, Yonetani S, Makino H, Watanabe T, Tsujimoto N, Takata S, Kurai D, Ishii H, Miyazaki Y, Takizawa H, Goto H (2014) Breakthrough invasive Candida glabrata in patients on micafungin: a novel FKS gene conversion correlated with sequential elevation of MIC. J Clin Microbiol 52(7):2709\u20132712. https:\/\/doi.org\/10.1128\/jcm.03593-13","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5105_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s44259-025-00102-6","volume":"3","author":"C Zajac","year":"2025","unstructured":"Zajac C, Scott NE, Kline S, Erayil SE, Selmecki A (2025) Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolates. npj Antimicrobials Resist 3(1):31","journal-title":"npj Antimicrobials Resist"},{"issue":"4","key":"5105_CR53","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/jof6040380","volume":"6","author":"A Apsemidou","year":"2020","unstructured":"Apsemidou A, F\u00fcller MA, Idelevich EA, Kurzai O, Tragiannidis A, Groll AH (2020) Candida lusitaniae Breakthrough Fungemia in an Immuno-Compromised Adolescent: Case Report and Review of the Literature. J Fungi 6(4):380","journal-title":"J Fungi"},{"issue":"12","key":"5105_CR54","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1128\/aac.42.12.3065","volume":"42","author":"R Franz","year":"1998","unstructured":"Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M, Morschh\u00e4user J (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42(12):3065\u20133072. https:\/\/doi.org\/10.1128\/aac.42.12.3065","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"5105_CR55","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1128\/aac.42.11.2932","volume":"42","author":"JL Lopez-Ribot","year":"1998","unstructured":"Lopez-Ribot JL, McAtee RK, Lee LN, Kirkpatrick WR, White TC, Sanglard D, Patterson TF (1998) Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 42(11):2932\u20132937. https:\/\/doi.org\/10.1128\/aac.42.11.2932","journal-title":"Antimicrob Agents Chemother"},{"key":"5105_CR56","doi-asserted-by":"crossref","unstructured":"Ostrowsky, Belinda, Jane Greenko, Eleanor Adams, Monica Quinn, Brittany O&rsquo, Vishnu Chaturvedi, Elizabeth Berkow et al. (2020) \"Candida auris isolates resistant to three classes of antifungal medications\u2014New York, 2019.\" MMWR. Morbidity and mortality weekly report 69.","DOI":"10.15585\/mmwr.mm6901a2"},{"key":"5105_CR57","doi-asserted-by":"crossref","unstructured":"Biagi MJ, Wiederhold NP, Gibas C, Wickes BL, Lozano V, Bleasdale SC, Danziger L (2019) Development of high-level echinocandin resistance in a patient with recurrent Candida auris candidemia secondary to chronic candiduria. In: 7 ed. Oxford University Press US, p ofz262","DOI":"10.1093\/ofid\/ofz262"},{"issue":"1","key":"5105_CR58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40779-021-00343-2","volume":"8","author":"Q-Y Zhang","year":"2021","unstructured":"Zhang Q-Y, Yan Z-B, Meng Y-M, Hong X-Y, Shao G, Ma J-J, Cheng X-R, Liu J, Kang J, Fu C-Y (2021) Antimicrobial peptides: mechanism of action, activity and clinical potential. Military Med Res 8(1):48. https:\/\/doi.org\/10.1186\/s40779-021-00343-2","journal-title":"Military Med Res"},{"key":"5105_CR59","doi-asserted-by":"publisher","unstructured":"Zhang Q, Choi K, Wang X, Xi L, Lu S (2025) The Contribution of Human Antimicrobial Peptides to Fungi. Int J Mol Sci 26(6). https:\/\/doi.org\/10.3390\/ijms26062494","DOI":"10.3390\/ijms26062494"},{"key":"5105_CR60","doi-asserted-by":"crossref","unstructured":"Min KH, Kim KH, Ki M-R, Pack SP (2024) Antimicrobial Peptides and Their Biomedical Applications: A Review. 13(9):794","DOI":"10.3390\/antibiotics13090794"},{"key":"5105_CR61","doi-asserted-by":"publisher","unstructured":"Buda De Cesare G, Cristy SA, Garsin DA, Lorenz MC (2020) Antimicrobial Peptides: a New Frontier in Antifungal Therapy. mBio 11(6). https:\/\/doi.org\/10.1128\/mBio.02123-20","DOI":"10.1128\/mBio.02123-20"},{"key":"5105_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fcimb.2020.00105","volume":"10","author":"M Fern\u00e1ndez de Ullivarri","year":"2020","unstructured":"Fern\u00e1ndez de Ullivarri M, Arbulu S, Garcia-Gutierrez E, Cotter PD (2020) Antifungal peptides as therapeutic agents. Front Cell Infect Microbiol 10:105","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"5105_CR63","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/ph6121543","volume":"6","author":"AA Bahar","year":"2013","unstructured":"Bahar AA, Ren D (2013) Antimicrobial peptides. Pharmaceuticals (Basel) 6(12):1543\u20131575. https:\/\/doi.org\/10.3390\/ph6121543","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"5105_CR64","doi-asserted-by":"publisher","first-page":"10039","DOI":"10.1007\/s11033-022-07572-1","volume":"49","author":"DM Mabrouk","year":"2022","unstructured":"Mabrouk DM (2022) Antimicrobial peptides: features, applications and the potential use against covid-19. Mol Biol Rep 49(10):10039\u201310050. https:\/\/doi.org\/10.1007\/s11033-022-07572-1","journal-title":"Mol Biol Rep"},{"key":"5105_CR65","doi-asserted-by":"publisher","unstructured":"Bin Hafeez A, Jiang X, Bergen PJ, Zhu Y (2021) Antimicrobial Peptides: An Update on Classifications and Databases. Int J Mol Sci 22(21). https:\/\/doi.org\/10.3390\/ijms222111691","DOI":"10.3390\/ijms222111691"},{"key":"5105_CR66","doi-asserted-by":"publisher","first-page":"1582863","DOI":"10.3389\/fmicb.2025.1582863","volume":"16","author":"Z Su","year":"2025","unstructured":"Su Z, Yu H, Lv T, Chen Q, Luo H, Zhang H (2025) Progress in the classification, optimization, activity, and application of antimicrobial peptides. Front Microbiol 16:1582863","journal-title":"Front Microbiol"},{"key":"5105_CR67","doi-asserted-by":"publisher","first-page":"582779","DOI":"10.3389\/fmicb.2020.582779","volume":"11","author":"Y Huan","year":"2020","unstructured":"Huan Y, Kong Q, Mou H, Yi H (2020) Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front Microbiol 11:582779. https:\/\/doi.org\/10.3389\/fmicb.2020.582779","journal-title":"Front Microbiol"},{"issue":"1","key":"5105_CR68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/0929866526666190822165812","volume":"27","author":"JK Boparai","year":"2020","unstructured":"Boparai JK, Sharma PK (2020) Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications. Protein Pept Lett 27(1):4\u201316. https:\/\/doi.org\/10.2174\/0929866526666190822165812","journal-title":"Protein Pept Lett"},{"issue":"2","key":"5105_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.22358\/jafs\/69998\/2017","volume":"26","author":"A Jozefiak","year":"2017","unstructured":"Jozefiak A, Engberg RM (2017) Insect proteins as a potential source of antimicrobial peptides in livestock production. A review. J Anim Feed Sci 26(2):87\u201399","journal-title":"J Anim Feed Sci"},{"key":"5105_CR70","doi-asserted-by":"publisher","first-page":"1008110","DOI":"10.37349\/eds.2025.1008110","volume":"3","author":"R Dilawari","year":"2025","unstructured":"Dilawari R, Chaubey GK, Priyadarshi N, Barik M, Parmar N (2025) Antimicrobial peptides: structure, function, mechanism of action and therapeutic applications in human diseases. Explor Drug Sci 3:1008110","journal-title":"Explor Drug Sci"},{"key":"5105_CR71","doi-asserted-by":"publisher","unstructured":"Davoudi M, Gavlighi HA, Javanmardi F, Benjakul S, Nikoo M (2024) Antimicrobial peptides derived from food byproducts: Sources, production, purification, applications, and challenges. 23(5):e13422. https:\/\/doi.org\/10.1111\/1541-4337.13422","DOI":"10.1111\/1541-4337.13422"},{"key":"5105_CR72","doi-asserted-by":"crossref","unstructured":"Alzain M, Daghistani H, Shamrani T, Almoghrabi Y, Daghistani Y, Alharbi OS, Sait AM, Mufrrih M, Alhazmi W, Alqarni MA (2025) Antimicrobial peptides: mechanisms, applications, and therapeutic potential. Infection and drug resistance:4385\u20134426","DOI":"10.2147\/IDR.S514825"},{"key":"5105_CR73","doi-asserted-by":"publisher","unstructured":"Li T, Li L, Du F, Sun L, Shi J, Long M, Chen Z (2021) Activity and Mechanism of Action of Antifungal Peptides from Microorganisms: A Review. Molecules 26(11). https:\/\/doi.org\/10.3390\/molecules26113438","DOI":"10.3390\/molecules26113438"},{"key":"5105_CR74","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.3389\/fmicb.2019.02993","volume":"10","author":"R Garcia-Rubio","year":"2019","unstructured":"Garcia-Rubio R, de Oliveira HC, Rivera J, Trevijano-Contador N (2019) The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Front Microbiol 10:2993. https:\/\/doi.org\/10.3389\/fmicb.2019.02993","journal-title":"Front Microbiol"},{"key":"5105_CR75","doi-asserted-by":"crossref","unstructured":"Ma H, Zhao X, Yang L, Su P, Fu P, Peng J, Yang N, Guo G (2020) Antimicrobial peptide AMP-17 affects Candida albicans by disrupting its cell wall and cell membrane integrity. Infection and drug resistance:2509\u20132520","DOI":"10.2147\/IDR.S250278"},{"issue":"2","key":"5105_CR76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/ph8020151","volume":"8","author":"BE Oyinloye","year":"2015","unstructured":"Oyinloye BE, Adenowo AF, Kappo AP (2015) Reactive Oxygen Species, Apoptosis, Antimicrobial Peptides and Human Inflammatory Diseases. Pharmaceuticals 8(2):151\u2013175","journal-title":"Pharmaceuticals"},{"key":"5105_CR77","doi-asserted-by":"publisher","unstructured":"Chen RC, Lan CY (2020) Human Antimicrobial Peptide Hepcidin 25-Induced Apoptosis in Candida albicans. Microorganisms 8(4). https:\/\/doi.org\/10.3390\/microorganisms8040585","DOI":"10.3390\/microorganisms8040585"},{"issue":"1","key":"5105_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/1574-6968.12450","volume":"355","author":"J Lee","year":"2014","unstructured":"Lee J, Lee DG (2014) Melittin triggers apoptosis in Candida albicans through the reactive oxygen species-mediated mitochondria\/caspase-dependent pathway. FEMS Microbiol Lett 355(1):36\u201342. https:\/\/doi.org\/10.1111\/1574-6968.12450","journal-title":"FEMS Microbiol Lett"},{"key":"5105_CR79","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3389\/fmicb.2019.03150","volume":"10","author":"SS Seyedjavadi","year":"2019","unstructured":"Seyedjavadi SS, Khani S, Eslamifar A, Ajdary S, Goudarzi M, Halabian R, Akbari R, Zare-Zardini H, Imani Fooladi AA, Amani J (2019) The antifungal peptide MCh-AMP1 derived from Matricaria chamomilla inhibits Candida albicans growth via inducing ROS generation and altering fungal cell membrane permeability. Front Microbiol 10:3150 Received 11 April 2023 Revised 12 May 2023","journal-title":"Front Microbiol"},{"issue":"1","key":"5105_CR80","doi-asserted-by":"publisher","first-page":"10327","DOI":"10.1038\/s41598-020-67041-2","volume":"10","author":"doN J Dias","year":"2020","unstructured":"J Dias doN, C Silva deS, AR deAra\u00fajo, JMT S, PH deHV J\u00fanior, WF C, M daGl\u00f3riadaS, P E, JR deSdeAL, AM N, P A, I S-P (2020) Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells. Sci Rep 10(1):10327. https:\/\/doi.org\/10.1038\/s41598-020-67041-2","journal-title":"Sci Rep"},{"issue":"3","key":"5105_CR81","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/0022034516679973","volume":"96","author":"B Bechinger","year":"2017","unstructured":"Bechinger B, Gorr SU (2017) Antimicrobial Peptides: Mechanisms of Action and Resistance. J Dent Res 96(3):254\u2013260. https:\/\/doi.org\/10.1177\/0022034516679973","journal-title":"J Dent Res"},{"issue":"3","key":"5105_CR82","first-page":"789","volume":"15","author":"GP Rodr\u00edguez-Casta\u00f1o","year":"2023","unstructured":"Rodr\u00edguez-Casta\u00f1o GP, Rosenau F, St\u00e4ndker L, Firacative C (2023) Antimicrobial Peptides: Avant-Garde Antifungal Agents to Fight against Medically. Important Candida Species 15(3):789","journal-title":"Important Candida Species"},{"issue":"2","key":"5105_CR83","doi-asserted-by":"publisher","first-page":"e0150196","DOI":"10.1371\/journal.pone.0150196","volume":"11","author":"J Han","year":"2016","unstructured":"Han J, Jyoti MA, Song H-Y, Jang WS (2016) Antifungal activity and action mechanism of histatin 5-halocidin hybrid peptides against Candida ssp. PLoS ONE 11(2):e0150196","journal-title":"PLoS ONE"},{"issue":"10","key":"5105_CR84","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/life12101581","volume":"12","author":"C Peng","year":"2022","unstructured":"Peng C, Liu Y, Shui L, Zhao Z, Mao X, Liu Z (2022) Mechanisms of Action of the Antimicrobial Peptide Cecropin in the Killing of Candida albicans. Life 12(10):1581","journal-title":"Life"},{"issue":"2","key":"5105_CR85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10123-022-00290-5","volume":"26","author":"S Shaban","year":"2023","unstructured":"Shaban S, Patel M, Ahmad A (2023) Fungicidal activity of human antimicrobial peptides and their synergistic interaction with common antifungals against multidrug-resistant Candida auris. Int Microbiol 26(2):165\u2013177. https:\/\/doi.org\/10.1007\/s10123-022-00290-5","journal-title":"Int Microbiol"},{"key":"5105_CR86","doi-asserted-by":"publisher","unstructured":"Talapko J, Me\u0161trovi\u0107 T, Juzba\u0161i\u0107 M, Tomas M, Eri\u0107 S, Horvat Aleksijevi\u0107 L, Beki\u0107 S, Schwarz D, Mati\u0107 S, Neuberg M, \u0160krlec I (2022) Antimicrobial Peptides-Mechanisms of Action, Antimicrobial Effects and Clinical Applications. Antibiot (Basel Switzerland) 11(10). https:\/\/doi.org\/10.3390\/antibiotics11101417","DOI":"10.3390\/antibiotics11101417"},{"issue":"4","key":"5105_CR87","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/idr15040046","volume":"15","author":"M Garvey","year":"2023","unstructured":"Garvey M (2023) Antimicrobial Peptides Demonstrate Activity against Resistant Bacterial Pathogens. Infect Dis Rep 15(4):454\u2013469. https:\/\/doi.org\/10.3390\/idr15040046","journal-title":"Infect Dis Rep"},{"issue":"1","key":"5105_CR88","doi-asserted-by":"publisher","first-page":"11885","DOI":"10.1038\/s41598-019-48322-x","volume":"9","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Zhou F, Su H, Zhang Y (2019) Structural design of microbicidal cationic oligomers and their synergistic interaction with azoles against Candida albicans. Sci Rep 9(1):11885. https:\/\/doi.org\/10.1038\/s41598-019-48322-x","journal-title":"Sci Rep"},{"key":"5105_CR89","doi-asserted-by":"publisher","first-page":"548620","DOI":"10.3389\/fmicb.2020.548620","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang Y, Wang C, Gao N, Lyu Y, Zhang L, Zhang S, Wang J, Shan A (2020) A novel dual-targeted \u03b1-helical peptide with potent antifungal activity against fluconazole-resistant Candida albicans clinical isolates. Front Microbiol 11:548620","journal-title":"Front Microbiol"},{"issue":"11","key":"5105_CR90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.02690-18","volume":"63","author":"W Woodburn Kathryn","year":"2019","unstructured":"Woodburn Kathryn W, Clemens LE, Jaynes J, Joubert L-M, Botha A, Nazik H, Stevens David A (2019) Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment. Antimicrob Agents Chemother 63(11):10. https:\/\/doi.org\/10.1128\/aac.02690-18. .1128\/aac.02690\u2009\u2013\u200902618","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"5105_CR91","doi-asserted-by":"publisher","first-page":"e0234520","DOI":"10.1128\/aac.02345-20","volume":"65","author":"V Duncan","year":"2021","unstructured":"Duncan V, Smith D, Simpson L, Lovie E, Katvars L, Berge L, Robertson J, Smith S, Munro C, Mercer D, O\u2019Neil D (2021) Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity. Antimicrob Agents Chemother 65(8):e0234520. https:\/\/doi.org\/10.1128\/aac.02345-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5105_CR92","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","volume":"1","author":"Y Lee","year":"2023","unstructured":"Lee Y, Robbins N, Cowen LE (2023) Molecular mechanisms governing antifungal drug resistance. npj Antimicrobials Resist 1(1):5. https:\/\/doi.org\/10.1038\/s44259-023-00007-2","journal-title":"npj Antimicrobials Resist"},{"issue":"3","key":"5105_CR93","doi-asserted-by":"publisher","first-page":"e17755","DOI":"10.1371\/journal.pone.0017755","volume":"6","author":"P-W Tsai","year":"2011","unstructured":"Tsai P-W, Yang C-Y, Chang H-T, Lan C-Y (2011) Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE 6(3):e17755","journal-title":"PLoS ONE"},{"issue":"2","key":"5105_CR94","doi-asserted-by":"publisher","first-page":"e1002501","DOI":"10.1371\/journal.ppat.1002501","volume":"8","author":"E Szafranski-Schneider","year":"2012","unstructured":"Szafranski-Schneider E, Swidergall M, Cottier F, Tielker D, Rom\u00e1n E, Pla J, Ernst JF (2012) Msb2 shedding protects Candida albicans against antimicrobial peptides. PLoS Pathog 8(2):e1002501","journal-title":"PLoS Pathog"},{"issue":"19","key":"5105_CR95","doi-asserted-by":"publisher","first-page":"10633","DOI":"10.3390\/ijms221910633","volume":"22","author":"C-M Hsu","year":"2021","unstructured":"Hsu C-M, Liao Y-L, Chang C-K, Lan C-Y (2021) Candida albicans Sfp1 Is Involved in the Cell Wall and Endoplasmic Reticulum Stress Responses Induced by Human Antimicrobial Peptide LL-37. Int J Mol Sci 22(19):10633","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5105_CR96","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/pathogens4040752","volume":"4","author":"S Puri","year":"2015","unstructured":"Puri S, Friedman J, Saraswat D, Kumar R, Li R, Ruszaj D, Edgerton M (2015) Candida albicans Shed Msb2 and Host Mucins Affect the Candidacidal Activity of Salivary Hst 5. Pathogens 4(4):752\u2013763","journal-title":"Pathogens"},{"key":"5105_CR97","doi-asserted-by":"publisher","unstructured":"El Shazely B, Yu G, Johnston PR, Rolff J (2020) Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC. Front Microbiol 11\u20132020. https:\/\/doi.org\/10.3389\/fmicb.2020.00103","DOI":"10.3389\/fmicb.2020.00103"},{"key":"5105_CR98","unstructured":"Freitas C, Lima S, Freire M, Paula A, Cantu\u00e1ria A, Oliveira J\u00fanior N, Santos T, Folha J, Ribeiro S, Dias S, Rezende T, Albuquerque P, Nicola A, de la Fuente C, Hancock R, Franco O, Felipe MS, Felipe S, Bosco D, Grande C (2018) Antimicrobial Agents and Chemotherapy. Antimicrobial Agents and Chemotherapy"},{"key":"5105_CR99","doi-asserted-by":"publisher","unstructured":"Sun C, Zhu L, Yang L, Tian Z, Jiao Z, Huang M, Peng J, Guo G (2024) Antimicrobial peptide AMP-17 induces protection against systemic candidiasis and interacts synergistically with fluconazole against Candida albicans biofilm. Front Microbiol Volume 15\u20132024. https:\/\/doi.org\/10.3389\/fmicb.2024.1480808","DOI":"10.3389\/fmicb.2024.1480808"},{"issue":"1","key":"5105_CR100","doi-asserted-by":"publisher","first-page":"17570","DOI":"10.1038\/s41598-018-35530-0","volume":"8","author":"E Roscetto","year":"2018","unstructured":"Roscetto E, Contursi P, Vollaro A, Fusco S, Notomista E, Catania MR (2018) Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates. Sci Rep 8(1):17570. https:\/\/doi.org\/10.1038\/s41598-018-35530-0","journal-title":"Sci Rep"},{"issue":"1","key":"5105_CR101","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12866-025-04055-8","volume":"25","author":"B Fayed","year":"2025","unstructured":"Fayed B (2025) Insights into Candida auris dispersal cells and their impact on antifungal resistance. BMC Microbiol 25(1):342. https:\/\/doi.org\/10.1186\/s12866-025-04055-8","journal-title":"BMC Microbiol"},{"issue":"3","key":"5105_CR102","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10534-025-00678-6","volume":"38","author":"B Fayed","year":"2025","unstructured":"Fayed B, El-Sayed HS, Luo S, Reda AE (2025) Comparative evaluation of biologically and chemically synthesized zinc oxide nanoparticles for preventing Candida auris biofilm. Biometals 38(3):817\u2013830. https:\/\/doi.org\/10.1007\/s10534-025-00678-6","journal-title":"Biometals"},{"issue":"5","key":"5105_CR103","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s13346-024-01749-w","volume":"15","author":"B Fayed","year":"2025","unstructured":"Fayed B (2025) Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects. Drug Deliv Transl Res 15(5):1496\u20131512. https:\/\/doi.org\/10.1007\/s13346-024-01749-w","journal-title":"Drug Deliv Transl Res"},{"key":"5105_CR104","doi-asserted-by":"publisher","unstructured":"Aguiar FLL, Santos NC, de Paula Cavalcante CS, Andreu D, Baptista GR, Gon\u00e7alves S (2020) Antibiofilm Activity on Candida albicans and Mechanism of Action on Biomembrane Models of the Antimicrobial Peptide Ctn[15\u201334]. Int J Mol Sci 21(21). https:\/\/doi.org\/10.3390\/ijms21218339","DOI":"10.3390\/ijms21218339"},{"issue":"1","key":"5105_CR105","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1128\/aac.47.1.262-267.2003","volume":"47","author":"A Lupetti","year":"2003","unstructured":"Lupetti A, Paulusma-Annema A, Welling MM, Dogterom-Ballering H, Brouwer CP, Senesi S, Van Dissel JT, Nibbering PH (2003) Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob Agents Chemother 47(1):262\u2013267. https:\/\/doi.org\/10.1128\/aac.47.1.262-267.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"5105_CR106","doi-asserted-by":"publisher","unstructured":"Fais R, Rizzato C, Franconi I, Tavanti A, Lupetti A (2022) Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species. Microbiol Spectr 10(4). https:\/\/doi.org\/10.1128\/spectrum.01240-22","DOI":"10.1128\/spectrum.01240-22"},{"key":"5105_CR107","doi-asserted-by":"publisher","unstructured":"Brouwer C, Theelen B, van der Linden Y, Sarink N, Rahman M, Alwasel S, Cafarchia C, Welling MM, Boekhout T (2024) Combinatory Use of hLF(1\u201311), a Synthetic Peptide Derived from Human Lactoferrin, and Fluconazole\/Amphotericin B against Malassezia furfur Reveals a Synergistic\/Additive Antifungal Effect. Antibiot (Basel) 13(8). https:\/\/doi.org\/10.3390\/antibiotics13080790","DOI":"10.3390\/antibiotics13080790"},{"key":"5105_CR108","doi-asserted-by":"publisher","unstructured":"Brouwer C, van der Linden Y, Carrasco MR, Alwasel S, Abalkhail T, Al-Otibi FO, Boekhout T, Welling MM (2025) Synthetic Human Lactoferrin Peptide hLF(1\u201311) Shows Antifungal Activity and Synergism with Fluconazole and Anidulafungin Towards Candida albicans and Various Non-Albicans Candida Species, Including Candidozyma auris. Antibiot (Basel) 14(7). https:\/\/doi.org\/10.3390\/antibiotics14070671","DOI":"10.3390\/antibiotics14070671"},{"issue":"1","key":"5105_CR109","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","volume":"23","author":"S Zheng","year":"2025","unstructured":"Zheng S, Tu Y, Li B, Qu G, Li A, Peng X, Li S, Shao C (2025) Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. J Translational Med 23(1):292. https:\/\/doi.org\/10.1186\/s12967-025-06321-9","journal-title":"J Translational Med"},{"key":"5105_CR110","unstructured":"Patel S, Saw S (2024) Daptomycin. StatPearls [Internet]. StatPearls Publishing"},{"issue":"5","key":"5105_CR111","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40262-025-01488-2","volume":"64","author":"PJ Zamri","year":"2025","unstructured":"Zamri PJ, Lim SMS, Sime FB, Roberts JA, Abdul-Aziz MH (2025) A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations. Clin Pharmacokinet 64(5):655\u2013689. https:\/\/doi.org\/10.1007\/s40262-025-01488-2","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"5105_CR112","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.3390\/ijms21072654","volume":"21","author":"K-T Cheng","year":"2020","unstructured":"Cheng K-T, Wu C-L, Yip B-S, Chih Y-H, Peng K-L, Hsu S-Y, Yu H-Y, Cheng J-W (2020) The Interactions between the Antimicrobial Peptide P-113 and Living Candida albicans Cells Shed Light on Mechanisms of Antifungal Activity and Resistance. Int J mol sci 21(7):2654","journal-title":"Int J mol sci"},{"key":"5105_CR113","doi-asserted-by":"publisher","first-page":"113357","DOI":"10.1016\/j.colsurfb.2023.113357","volume":"227","author":"R Cagliani","year":"2023","unstructured":"Cagliani R, Fayed B, Jagal J, Shakartalla SB, Soliman SSM, Haider M (2023) Peptide-functionalized zinc oxide nanoparticles for the selective targeting of breast cancer expressing placenta-specific protein 1. Colloids Surf B Biointerfaces 227:113357. https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113357","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5105_CR114","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3389\/fimmu.2020.02177","volume":"11","author":"DK Mercer","year":"2020","unstructured":"Mercer DK, O\u2019Neil DA (2020) Innate inspiration: antifungal peptides and other immunotherapeutics from the host immune response. Front Immunol 11:2177","journal-title":"Front Immunol"},{"issue":"4","key":"5105_CR115","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.fbr.2012.11.001","volume":"26","author":"VMS Duncan","year":"2013","unstructured":"Duncan VMS, O\u2019Neil DA (2013) Commercialization of antifungal peptides. Fungal Biol Rev 26(4):156\u2013165","journal-title":"Fungal Biol Rev"},{"issue":"5","key":"5105_CR116","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijantimicag.2009.05.003","volume":"34","author":"E Rubinchik","year":"2009","unstructured":"Rubinchik E, Dugourd D, Algara T, Pasetka C, Friedland HD (2009) Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models. Int J Antimicrob Agents 34(5):457\u2013461","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"5105_CR117","doi-asserted-by":"publisher","first-page":"e24122","DOI":"10.1002\/pep2.24122","volume":"111","author":"HB Koo","year":"2019","unstructured":"Koo HB, Seo J (2019) Antimicrobial peptides under clinical investigation. Pept Sci 111(5):e24122","journal-title":"Pept Sci"},{"key":"5105_CR118","doi-asserted-by":"publisher","unstructured":"Bras G, Satala D, Juszczak M, Kulig K, Wronowska E, Bednarek A, Zawrotniak M, Rapala-Kozik M, Karkowska-Kuleta J (2024) Secreted Aspartic Proteinases: Key Factors in Candida Infections and Host-Pathogen Interactions. Int J Mol Sci 25(9). https:\/\/doi.org\/10.3390\/ijms25094775","DOI":"10.3390\/ijms25094775"},{"issue":"11","key":"5105_CR119","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/jof8111173","volume":"8","author":"G Pinilla","year":"2022","unstructured":"Pinilla G, Coronado YT, Chaves G, Mu\u00f1oz L, Navarrete J, Salazar LM, Taborda CP, Mu\u00f1oz JE (2022) In Vitro Antifungal Activity of LL-37 Analogue Peptides against Candida spp. J Fungi 8(11):1173","journal-title":"J Fungi"},{"issue":"2","key":"5105_CR120","doi-asserted-by":"publisher","first-page":"e56004","DOI":"10.1371\/journal.pone.0056004","volume":"8","author":"H-x Ji","year":"2013","unstructured":"Ji H-x, Zou Y-l, Duan J-j, Jia Z-r, Li X-j, Wang Z, Li L, Li Y-w, Liu G-y, Tong M-Q (2013) The synthetic melanocortin (CKPV) 2 exerts anti-fungal and anti-inflammatory effects against Candida albicans vaginitis via inducing macrophage M2 polarization. PLoS ONE 8(2):e56004","journal-title":"PLoS ONE"},{"issue":"5","key":"5105_CR121","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.02117-18","volume":"63","author":"DK Mercer","year":"2019","unstructured":"Mercer DK, Stewart CS, Miller L, Robertson J, Duncan VMS, O\u2019Neil DA (2019) Improved methods for assessing therapeutic potential of antifungal agents against dermatophytes and their application in the development of NP213, a novel onychomycosis therapy candidate. Antimicrob Agents Chemother 63(5):10\u20131128","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5105_CR122","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/gels9020165","volume":"9","author":"D Bellotti","year":"2023","unstructured":"Bellotti D, D\u2019Accolti M, Pula W, Huang N, Simeliere F, Caselli E, Esposito E, Remelli M (2023) Calcitermin-Loaded Smart Gels Activity against Candida albicans: A Preliminary In Vitro Study. Gels 9(2):165","journal-title":"Gels"},{"key":"5105_CR123","doi-asserted-by":"publisher","first-page":"1528583","DOI":"10.3389\/fcimb.2025.1528583","volume":"15","author":"M Sadeeq","year":"2025","unstructured":"Sadeeq M, Li Y, Wang C, Hou F, Zuo J, Xiong P (2025) Unlocking the power of antimicrobial peptides: advances in production, optimization, and therapeutics. Front Cell Infect Microbiol 15:1528583. https:\/\/doi.org\/10.3389\/fcimb.2025.1528583","journal-title":"Front Cell Infect Microbiol"},{"key":"5105_CR124","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pep.2017.08.003","volume":"140","author":"T Deng","year":"2017","unstructured":"Deng T, Ge H, He H, Liu Y, Zhai C, Feng L, Yi L (2017) The heterologous expression strategies of antimicrobial peptides in microbial systems. Protein Expr Purif 140:52\u201359. https:\/\/doi.org\/10.1016\/j.pep.2017.08.003","journal-title":"Protein Expr Purif"},{"issue":"2","key":"5105_CR125","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2225\/vol10-issue2-fulltext-13","volume":"10","author":"F Guzm\u00e1n","year":"2007","unstructured":"Guzm\u00e1n F, Barberis S, Illanes A (2007) Peptide synthesis: chemical or enzymatic. Electron J Biotechnol 10(2):279\u2013314","journal-title":"Electron J Biotechnol"},{"issue":"11","key":"5105_CR126","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.peptides.2010.08.008","volume":"31","author":"B Bommarius","year":"2010","unstructured":"Bommarius B, Jenssen H, Elliott M, Kindrachuk J, Pasupuleti M, Gieren H, Jaeger KE, Hancock RE, Kalman D (2010) Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31(11):1957\u20131965. https:\/\/doi.org\/10.1016\/j.peptides.2010.08.008","journal-title":"Peptides"},{"issue":"1","key":"5105_CR127","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41598-022-04931-7","volume":"12","author":"L K\u00e4\u00dfer","year":"2022","unstructured":"K\u00e4\u00dfer L, Rotter M, Coletta L, Salzig D, Czermak P (2022) Process intensification for the continuous production of an antimicrobial peptide in stably-transformed Sf-9 insect cells. Sci Rep 12(1):1086","journal-title":"Sci Rep"},{"issue":"3","key":"5105_CR128","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/1097-0282(2000)55:3<227::AID-BIP50>3.0.CO;2-7","volume":"55","author":"L Andersson","year":"2000","unstructured":"Andersson L, Blomberg L, Flegel M, Lepsa L, Nilsson B, Verlander M (2000) Large-scale synthesis of peptides. Pept Sci 55(3):227\u2013250","journal-title":"Pept Sci"},{"issue":"1","key":"5105_CR129","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41467-023-37003-z","volume":"14","author":"S Chaudhary","year":"2023","unstructured":"Chaudhary S, Ali Z, Tehseen M, Haney EF, Pantoja-Angles A, Alshehri S, Wang T, Clancy GJ, Ayach M, Hauser C, Hong PY, Hamdan SM, Hancock REW, Mahfouz M (2023) Efficient in planta production of amidated antimicrobial peptides that are active against drug-resistant ESKAPE pathogens. Nat Commun 14(1):1464. https:\/\/doi.org\/10.1038\/s41467-023-37003-z","journal-title":"Nat Commun"},{"key":"5105_CR130","doi-asserted-by":"publisher","unstructured":"De Luca C, Lievore G, Bozza D, Buratti A, Cavazzini A, Ricci A, Macis M, Cabri W, Felletti S, Catani M (2021) Downstream Processing of Therapeutic Peptides by Means of Preparative Liquid Chromatography. Molecules 26(15). https:\/\/doi.org\/10.3390\/molecules26154688","DOI":"10.3390\/molecules26154688"},{"issue":"1","key":"5105_CR131","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijpharm.2016.12.051","volume":"518","author":"LC Wu","year":"2017","unstructured":"Wu LC, Chen F, Lee SL, Raw A, Yu LX (2017) Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides. Int J Pharm 518(1):320\u2013334. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.12.051","journal-title":"Int J Pharm"},{"issue":"1","key":"5105_CR132","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1208\/s12248-014-9681-9","volume":"17","author":"JL Furman","year":"2015","unstructured":"Furman JL, Chiu M, Hunter MJ (2015) Early engineering approaches to improve peptide developability and manufacturability. AAPS J 17(1):111\u2013120. https:\/\/doi.org\/10.1208\/s12248-014-9681-9","journal-title":"AAPS J"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05105-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05105-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05105-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:02:49Z","timestamp":1790629369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-05105-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":132,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5105"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-05105-8","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"541"}}